Cite
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs
MLA
Mu F, et al. “Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs.” Cancer Management and Research, vol. ume 15, Apr. 2023, pp. 351–62. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0a1c0a3d455547d38b1dbd18ce196a21&authtype=sso&custid=ns315887.
APA
Mu F, Fan B, Li B, Qin W, Li H, Wang C, Zou B, Wang S, & Wang L. (2023). Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs. Cancer Management and Research, ume 15, 351–362.
Chicago
Mu F, Fan B, Li B, Qin W, Li H, Wang C, Zou B, Wang S, and Wang L. 2023. “Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs.” Cancer Management and Research ume 15 (April): 351–62. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0a1c0a3d455547d38b1dbd18ce196a21&authtype=sso&custid=ns315887.